Discontinued — last reported Q3 '25
Current Assets
Trading assets
Biogen Trading assets increased by 11.5% to $900.00M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Trading assets shows a downward trend with a -14.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ3 2025
How to read this metric
An increase suggests higher market activity or speculative positioning, while a decrease may indicate a shift toward more conservative liquidity management.
Detailed definition
Trading assets represent financial instruments acquired primarily for the purpose of selling them in the near term to ge...
Peer comparison
Common in financial services firms; less common in pure manufacturing, though present in captive finance arms.
Metric ID:
fin_trading_assetsHistorical Data
12 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.31B | $1.41B | $1.54B | $2.01B | $2.14B | $1.25B | $1.47B | $2.14B | $3.46B | $97.60M | $807.20M | $900.00M |
| QoQ Change | — | +8.0% | +9.0% | +30.2% | +6.5% | -41.7% | +18.3% | +45.4% | +61.5% | -97.2% | +727.0% | +11.5% |
| YoY Change | — | — | — | — | +63.2% | -11.9% | -4.4% | +6.8% | +62.0% | — | — | — |
Range$97.60M – $3.46B
CAGR-12.7%
Avg YoY Growth+23.2%
Median YoY Growth+6.8%
Current Streak2 quarters growth
Trading assets at Other Companies
Frequently Asked Questions
- What is Biogen's trading assets?
- Biogen (BIIB) reported trading assets of $900.00M in Q1 2026.
- What is the long-term trend for Biogen's trading assets?
- Over 3 years (2020 to 2025), Biogen's trading assets has grown at a -14.2% compound annual growth rate (CAGR), from $1.28B to $807.20M.
- What does trading assets mean?
- Financial assets held for short-term trading purposes and recorded at current market value.